WHO

September 27, 2021

Covid origins probe to be relaunched with fresh team

A joint WHO-China inquiry had dismissed the possibility that the virus had emerged accidentally from a laboratory as 'extremely unlikely'.

September 02, 2021
WHO warns new Mu variant of COVID-19 could be more vaccine-resistant

Mu - also known by its scientific name as B.1.621 - was first identified in Colombia in January 2021, and since then, there have been "sporadic reports" of cases and some larger outbreaks in South America and Europe.
August 25, 2021
Covid in India maybe entering some stage of endemicity: WHO

The endemic stage is when a population learns to live with a virus. It's very different from the epidemic stage when the virus overwhelms a population.
August 18, 2021
WHO identifies counterfeit versions of Covishield in India

Covishield is the Indian-made version of AstraZeneca's jab and is the most widely used vaccine in India with more than 486 million doses administered so far.
August 01, 2021
Global spike in Covid cases may lead to dangerous variants: WHO

According to virologists, the SARS-CoV-2 virus that causes COVID-19, might have already developed into extra threatening kinds which have, to date, evaded detection.
July 22, 2021
China rejects WHO plan to study COVID-19 origin

The WHO this month proposed a second phase of studies into the origins of the coronavirus in China, including audits of laboratories and markets in the city of Wuhan, calling for transparency from authorities.
July 10, 2021
Decision on emergency use listing of Covaxin likely in 4-6 weeks: WHO

Soumya Swaminathan said the WHO is reviewing Covaxin as its manufacturer Bharat Biotech is now uploading its entire data on the health body's portal.

Covid origins probe to be relaunched with fresh team

WHO warns new Mu variant of COVID-19 could be more vaccine-resistant

Covid in India maybe entering some stage of endemicity: WHO

WHO identifies counterfeit versions of Covishield in India

Global spike in Covid cases may lead to dangerous variants: WHO

China rejects WHO plan to study COVID-19 origin

Decision on emergency use listing of Covaxin likely in 4-6 weeks: WHO

World in a 'dangerous period' with delta variant: WHO

Delta variant to become dominant strain of COVID-19 in coming months: WHO

WHO approves 2nd Chinese vaccine for emergency use